There’s also a lot to be excited about in women’s health. 👀
Check out news pushing the field forward. 🚀 Share this with 3 friends who you think need to see it and follow us for more.
#WomensHealth #WHAMNow
Postmenopausal bleeding shouldn’t be ignored. But are we always using the right test at the right time? 🤔
In our first WHAM Perspective, WHAM Research Collaborative member Steven R. Goldstein, MD, MSCP, explores ACOG’s April 2026 shift toward endometrial sampling as the initial evaluation for postmenopausal bleeding — and what it could mean for women’s care.
🔍 He looks at:
🔸 Diagnostic accuracy
🔸 Unnecessary invasive procedures
🔸 Persistent or recurrent bleeding
🔸 Access to care
🔸 Early cancer detection
At the heart of it all: How do we catch cancer early while making sure every woman gets the right care for her individual situation?
📚Read Dr. Goldstein’s full perspective at our link in bio.
#WHAMNow #Menopause #PostMenopause #WomensHealth
Big ideas. Big impact. Big recognition. 💥
We’re celebrating WHAM Board Member Sheila Ann Mikhail, CEO & Co-founder of M34 Inc., who was named one of @endpointnews’ 20 Women Changing the Biopharma Industry in 2026!
For nearly 25 years, Sheila has built companies, advanced gene therapies, and championed patients with rare diseases. Her work connects scientific innovation with a clear imperative: bringing better treatments to the people who need them. 🔬
Following her own breast cancer diagnosis, Sheila brought that same determination to women’s health, advocating for better breast cancer screening and expanded access to supplemental screening for women with dense breasts.
She brings entrepreneurial vision, deep scientific expertise, and a determined commitment to her work.💡
We are proud to count her among our Board members and congratulate her on this well-deserved recognition.
Read the full Endpoints News feature → link in bio.
#WomensHealth #WHAMNow #BioPharma #Cancer #WomensCancers
These numbers are hard to ignore.😬
🔸 32%
Women were 32% more likely to die within 30 days after surgery when operated on by a male surgeon.
🔸 60%
Women experienced roughly 60% more global low back pain burden than men.
🔸 52%
Only about half of women diagnosed with ovarian cancer survive five years.
🔸 1 in 2
About half of women experience urinary incontinence.
🔸 1 in 6
By their 40s, about 1 in 6 women have been diagnosed with uterine fibroids.
These are reminders of how much we still need to learn.
More research. More data. More answers.💡
Support women’s health research → whamnow.org/donate
#WHAMNow #WomensHealth #WomensHealthResearch #GenderHealthGap #MedicalResearch #Healthcare
Medicine doesn’t always work the same way for everyone‼️
🏆2025 WHAM Edge Award recipient Dr. Brian Aguado from UC San Diego is using AI and digital medicine tools to uncover why women and men can respond differently to the same cardiovascular treatments.
The WHAM Edge Awards support the researchers pushing women’s health forward with innovative approaches and bold questions.
🌟Donate at our link in bio to fund the next generation of breakthroughs
#WHAMEdgeAwards #WomensHealth #WomensHealthResearch #WHAMNow
🧠 Menopause and brain health? There’s more to the story.
New research in Nature Medicine found important connections between menopause-related changes in the body and brain health later in life.
🔎 Key findings:
• Menopause was linked to changes in proteins related to brain health.
• These changes were more closely tied to hormone changes than age.
• Across nearly 12,000 women, greater menopause-related changes were associated with worse cognitive health.
• Greater menopause-related changes were also associated with a higher likelihood of developing Alzheimer’s.
We’re thrilled to watch Dr. Emily Jacobs, Director of the Initiative and a member of the WHAM Research Collaborative, pioneering critical projects in women’s brain health.🔬
We’re also proud to see Dr. Laura Pritschet from UPenn, a recipient of last year’s WHAM Edge Award, among the researchers behind this work. 👏
More research. More answers. Better understanding of women’s health across the lifespan.
🔗 Read the research at the link in our bio.
#WomensHealth #Menopause #BrainHealth #Alzheimers #WHAMNow
Follow us on LinkedIn to receive the latest in women’s health: @Women’s Health Access Matters

Join us in support of our 3Not30 goals. WHAM has developed an action plan to create impactful and sustainable change by identifying the economic impact of accelerating research and investment in businesses focused on the health of women. Your voices need to be included. These goals will affect your health and the health and well-being of future generations. Let’s eliminate the health gap. Help advance the health of women by supporting these goals:
Together, we can create the kind of impact and sustainable change to improve the health of women, their families and society. Won’t you join us? Sign up to support the 3Not30 goals and receive the latest in women’s health.
Make a donation, join the community, or help us spread the word about WHAM and our work—every little bit helps, and we are deeply appreciative of your support.
Women are 51% of the population but receive only a fraction of biomedical research funding. Sex differences are still often ignored, even in diseases that hit women hardest. Advancing sex-based research closes that gap, sparks innovation, and delivers more precise care for everyone. Support the future of health—for women, and for all.
This will close in 0 seconds
Four out of five Americans with autoimmune disease are women—40 million lives impacted—yet the science hasn’t kept up. In 2019, only 7 % of the NIH’s rheumatoid arthritis budget focused on women. Dedicated funding can pinpoint why women are so vulnerable and drive better diagnostics, therapies, and quality of life. Fuel research that will change lives.
This will close in 0 seconds
Women make up two-thirds of Alzheimer’s cases and are twice as likely to suffer depression—yet we still don’t know why. Targeted, sex-specific studies can reveal the biological and clinical differences that unlock earlier diagnosis, smarter treatments, and healthier minds. Your gift drives that discovery.
This will close in 0 seconds
Most cancer studies still default to male models, overlooking critical sex differences in how cancers start, spread, and respond to therapy. Lung cancer now kills more women than breast, ovarian, and cervical cancers combined, and rates are soaring among young, non-smoking women. Boosting sex-based cancer research will reveal why—and lead to breakthroughs in screening, care, and survival. Help us accelerate that work.
This will close in 0 seconds
Heart disease is the No. 1 killer of women, but it remains underfunded, under-researched, and underdiagnosed. Nearly half of women over 20 have cardiovascular disease, pregnancy heart risks are widespread, and women are 50% more likely to die after a heart attack. Focused research can rewrite those odds—changing how heart disease is detected, treated, and prevented in women. Invest in saving women’s hearts.
This will close in 0 seconds